Zurück

Hepatitis B

Geschlecht Beides

Alter von 18 bis 45

Rauchgewohnheiten Nicht

BMI von 19 bis 30

Berechnen Sie Ihren BMI hier

Ort der Studie

 

Study of an investigational compound that is being developed for the treatment of chronic hepatitis B

 

Besonderheiten (auf Englisch)

  • You are between 18 and 45 years old and are living in The Netherlands, Belgium or Germany.
  • You do not smoke or do use other nicotine containing products
  • Your Body Mass Index (BMI) is between 19.0 and 30.0 kg/m2. The BMI shows the relation between body weight in kilograms and length in meters.
  • Women are only allowed to participate in this study if they are using non-hormonal contraception (intrauterine device, IUD) or if they (or their partner) have been surgically sterilized.
  • Men with fertile female partners are allowed to participate only if they are using a condom in combination with a contraceptive measure by their female partner or if they have been surgically sterilized.
  • You cannot have participated in another clinical trial in the 60 days before the start of this study.
  • To determine if you are suitable to participate in this study, you will undergo a medical screening. This will be performed in Groningen. When you pass the medical screening a second appointment will be made to perform an X-ray of the chest.

 

Vergütung (auf Englisch)

You will receive a gross compensation of €3608 for participation in group 1 of this study.
For participation in groups 2 or 3 of the study, you will receive a gross compensation of €2786.
For participation in group 4 of the study, you will receive a gross compensation of €2166.

Travelling expenses will be reimbursed based on the distance traveled (€0.19 net per kilometer) with a minimum of €12 and a maximum of €160 (840 kilometers) per return, regardless of the mode of transportation.

The study consists of maximally 4 groups. Based on the results in the previous group(s), it will be decided if the next group will be performed.

Group 1 consists of 1 period during which you will stay in our research facility in Groningen for 24 days (23 nights).
Groups 2 & 3 consist of 1 period during which you will stay in our research facility in Groningen for 18 days (17 nights).
Group 4 consists of 1 period during which you will stay in our research facility in Groningen for 13 days (12 nights).
For all groups there will be a follow-up visit between 5 and 9 days after discharge from the research facility.

Please note: You have to be available for all dates of the group of choice to be able to participate in this study. These are the currently planned dates; however, these may be subject to change.

 

Group 1f

€ 3.608,-

24 Tage Aufenthalt

8 Nov 2020 bis einschl. 1 Dez 2020

Anmerkung

Follow-up by appointment between 06 – 10 december 2020

Group 4f

€ 2.166,-

13 Tage Aufenthalt

16 Nov 2020 bis einschl. 28 Nov 2020

Anmerkung

Follow-up by appointment between 03 – 07 december 2020

Group 1g

€ 3.608,-

24 Tage Aufenthalt

30 Nov 2020 bis einschl. 23 Dez 2020

Anmerkung

Follow-up by appointment between 28 december 2020 – 01 january 2021

 

Andere Studien, die möglicherweise auch für Sie geeignet sind
  • Keine passenden Studien